(Q43544761)

24 November 2017

0 references

Type I and type III interferon-induced immune response: it's a matter of kinetics and magnitude (English)

1 reference

24 November 2017

David Olagnier

1

0 references

author name string

John Hiscott

series ordinal

2

1 reference

PubMed ID

24677190

24 November 2017

language of work or name

English

0 references

publication date

28 February 2014

1 reference

24 November 2017

1 reference

24 November 2017

59

1 reference

24 November 2017

4

1 reference

24 November 2017

1225-1228

1 reference

Interferon-lambda: a new addition to an old family

24 November 2017

1 reference

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

21 January 2018

1 reference

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

21 January 2018

1 reference

A diverse range of gene products are effectors of the type I interferon antiviral response

21 January 2018

1 reference

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

21 January 2018

1 reference

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

21 January 2018

1 reference

Biological activity of interleukins-28 and -29: comparison with type I interferons

21 January 2018

1 reference

Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities

21 January 2018

1 reference

Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression

21 January 2018

1 reference

Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus

21 January 2018

1 reference

Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells.

21 January 2018

1 reference

HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons

21 January 2018

1 reference

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

21 January 2018

1 reference

Human interferon-lambda3 is a potent member of the type III interferon family.

21 January 2018

1 reference

Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.26959

1 reference

24 November 2017

1 reference

PubMed ID

24677190